Cargando…
The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (AMD; nAMD) which occurs more commonly in Asian populations as compared to Caucasians. PCV and nAMD share pathological mechanisms, including pathological expression of vascular endothelial growth fac...
Autores principales: | Teo, Kelvin Yi Chong, Gillies, Mark, Fraser-Bell, Samantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165414/ https://www.ncbi.nlm.nih.gov/pubmed/30177632 http://dx.doi.org/10.3390/ijms19092611 |
Ejemplares similares
-
Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Yanagi, Yasuo, et al.
Publicado: (2022) -
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Kondo, Naoshi, et al.
Publicado: (2009) -
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019) -
Evaluation of the association of C5 with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Liu, Ke, et al.
Publicado: (2019) -
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Shen, Yinchen, et al.
Publicado: (2022)